TORONTO, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Revive Therapeutics Ltd. (“Revive” or the “Company”) (OTCQB: RVVTF) (CSE: RVV) (FRANKFURT:31R), a specialty life sciences company focused on the research and development of therapeutics for infectious diseases and medical countermeasures, announced today an update on its research and development focus on Bucillamine. Bucillamine, an oral thiol-based drug with anti-inflammatory and antiviral properties, has a well-known safety profile and is prescribed in the treatm ...

VANCOUVER, British Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Entrée Resources Ltd. (TSX:ETG; OTCQB:ERLFF – the “Company” or “Entrée”) is pleased to announce its Joint Venture Agreement with Oyu Tolgoi LLC (“OTLLC”), which the parties have been operating under since formation of the Entrée/Oyu Tolgoi joint venture on June 30, 2008 (the “Joint Venture”), has been formally executed and delivered by the parties. Stephen Scott, the Company’s President & CEO commented, “I am extremely happy that the Joint Ventu ...

VANCOUVER, British Columbia, Feb. 03, 2025 (GLOBE NEWSWIRE) -- NorthWest Copper (“NorthWest” or “the Company”) (TSX-V: NWST) announces that it has engaged Danayi Capital Corp. (“Danayi”) to provide certain investor relations and digital marketing services to the Company. Danayi is a marketing, advertising and public awareness firm based out of Vancouver, British Columbia, specializing in the mining and metals sector. Danayi has agreed to comply with all applicable securities laws and the policies of the TSX ...

BOSTON, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ:PRAX), a clinical-stage biopharmaceutical company translating genetic insights into the development of therapies for central nervous system (CNS) disorders characterized by neuronal excitation-inhibition imbalance, today announced that it will be participating in two upcoming investor conferences: Praxis management will be participating in a fireside chat at the Guggenheim Securities SMID Cap Biotechnology Conference, taking ...

ST. LOUIS, Feb. 03, 2025 (GLOBE NEWSWIRE) -- BellRing Brands, Inc. (NYSE:BRBR) ("BellRing"), a holding company operating in the global convenient nutrition category, today reported results for the first fiscal quarter ended December 31, 2024. Highlights: First quarter net sales of $532.9 millionOperating profit of $115.3 million, net earnings of $76.9 million and Adjusted EBITDA* of $125.3 millionRaised fiscal year 2025 net sales outlook to $2.26-$2.34 billion and Adjusted EBITDA* outlook to $470-$500 milli ...

LOS ANGELES, Feb. 03, 2025 (GLOBE NEWSWIRE) -- RBB Bancorp (NASDAQ:RBB) and its subsidiaries, Royal Business Bank (the "Bank") and RBB Asset Management Company ("RAM"), collectively referred to herein as the "Company," announced financial results for the quarter and fiscal year ended December 31, 2024. Fourth Quarter 2024 Highlights Net income totaled $4.4 million, or $0.25 diluted earnings per shareReturn on average assets of 0.44%, compared to 0.72% for the quarter ended September 30, 2024Net interest mar ...

LOS ANGELES, Feb. 03, 2025 (GLOBE NEWSWIRE) -- RBB Bancorp (NASDAQ:RBB) and its subsidiaries, Royal Business Bank (the “Bank”) and RBB Asset Management Company (“RAM”), collectively referred to herein as the “Company,” announced financial results for the quarter and fiscal year ended December 31, 2024. Fourth Quarter 2024 Highlights Net income totaled $4.4 million, or $0.25 diluted earnings per shareReturn on average assets of 0.44%, compared to 0.72% for the quarter ended September 30, 2024Net interest mar ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Applied Therapeutics, Inc. ("Applied Therapeutics" or the "Company") (NASDAQ: APLT) investors of a class action representing investors that bought securities between January 3, 2024 and December 2, 2024, inclusive (the "Class Period"). Applied Therapeutics investors have until February 18, 2025 to file a lead plaintiff motion. Investors are enc ...

Investors can contact the law firm at no cost to learn more about recovering their losses LOS ANGELES, Feb. 03, 2025 (GLOBE NEWSWIRE) -- The Portnoy Law Firm advises Regeneron Pharmaceuticals, Inc. ("Regeneron" or the "Company") (NASDAQ: REGN) investors of a class action representing investors that bought securities between November 2, 2023 and October 30, 2024, inclusive (the "Class Period"). Regeneron investors have until March 10, 2025 to file a lead plaintiff motion. Investors are encouraged to contact ...

OKLAHOMA CITY, Feb. 03, 2025 (GLOBE NEWSWIRE) -- Murphy Law Firm is investigating claims on behalf of all individuals (including students, parents, and teachers) whose personal and confidential information was compromised in the data breach involving Delta County Memorial Hospital District. To join the class action lawsuit, visit our site HERE. On or around May 30, 2024, Delta County Memorial Hospital District (“Delta” or “Delta Health”) detected suspicious activity on its computer network, indicating a dat ...